Biocard COVID-19 IgM, IgG Test

The First Reliable and Rapid Antibody based Test

Qualitative detection of IgM and IgG antibodies against COVID-19 in human serum, plasma, and whole blood
Based on Lateral flow immunochromatographic principle
Results in less than 10 minutes
High Sensitivity (97.4%) & Specificity (98%)

Simultaneous surveillance and detection of both the Covid-19 antibodies (IgM and IgG), aiding the diagnosis of present and past infection
Highly Sensitive (97.4%) and robust test enabling the detection of infection even at low levels of antibody concentration
Highly Specific (98%) and no cross reactivity observed with several bacterial, viral and parasitic microorganisms
No inhibition or false positive results when tested with several potential inhibitory substances
Straightforward result interpretation

request for quote